Telomerase-immortalized non-malignant human prostate epithelial cells retain the properties of multipotent stem cells

Experimental Cell Research

Volumn 314, Issue 1, 2008, Pages 92-102

  Li, Hongzhen ^a   Zhou, JianJun ^b   Miki, Jun ^a   Furusato, Bungo ^c   Gu, Yongpeng ^a   Srivastava, Shiv ^a   McLeod, David G ^a   Vogel, Jonathan C ^b   Rhim, Johng S ^a  

^a UNIFORMED SERVICES UNIVERSITY OF THE HEALTH SCIENCES   (United States)

^b NATIONAL CANCER INSTITUTE   (United States)

^c ARMED FORCES INSTITUTE OF PATHOLOGY   (United States)

Author keywords

hTERT; Immortalization; Prostate; Stem cell

Indexed keywords

CD133 ANTIGEN; CELL MARKER; CHROMOGRANIN A; CYTOKERATIN 18; DESMIN; HERMES ANTIGEN; OCTAMER TRANSCRIPTION FACTOR 4; PROTEIN P63; TELOMERASE REVERSE TRANSCRIPTASE; VERY LATE ACTIVATION ANTIGEN 1; VIMENTIN;

AGED; ARTICLE; CELL DIFFERENTIATION; CELL TRANSFORMATION; CONTROLLED STUDY; EMBRYONIC STEM CELL; ENDOCRINE CELL; HUMAN; HUMAN CELL; MALE; MESENCHYME CELL; MULTIPOTENT STEM CELL; NERVE CELL; NONOBESE DIABETIC MOUSE; PRIORITY JOURNAL; PROSTATE EPITHELIUM; SCID MOUSE;

BOVINAE; MUS;

EID: 36549019589     PISSN: 00144827     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.yexcr.2007.08.011     Document Type: Article

References (52)

1. Gronberg H. Prostate cancer epidemiology. Lancet 361 (2003) 859-864
2. Isaacs J.T., and Coffey D.S. Etiology and disease process of benign prostatic hyperplasia. Prostate, Suppl. 2 (1989) 33-50
3. Bonkhoff H. Role of the basal cells in premalignant changes of the human prostate: a stem cell concept for the development of prostate cancer. Eur. Urol. 30 (1996) 201-205
4. Xin L., Ide H., Kim Y., Dubey P., and Witte O.N. In vivo regeneration of murine prostate from dissociated cell populations of postnatal epithelia and urogenital sinus mesenchyme. Proc. Natl. Acad. Sci. U. S. A. 100 Suppl. 1 (2003) 11896-11903
5. Tsujimura A., Koikawa Y., Salm S., Takao T., Coetzee S., Moscatelli D., Shapiro E., Lepor H., Sun T.T., and Wilson E.L. Proximal location of mouse prostate epithelial stem cells: a model of prostatic homeostasis. J. Cell Biol. 157 (2002) 1257-1265
6. Taylor R.A., Cowin P.A., Cunha G.R., Pera M., Trounson A.O., Pedersen J., and Risbridger G.P. Formation of human prostate tissue from embryonic stem cells. Nat. Methods 3 (2006) 179-181
7. Schalken J.A., and van Leenders G. Cellular and molecular biology of the prostate: stem cell biology. Urology 62 (2003) 11-20
8. Hudson D.L., O'Hare M., Watt F.M., and Masters J.R. Proliferative heterogeneity in the human prostate: evidence for epithelial stem cells. Lab. Invest. 80 (2000) 1243-1250
9. Collins A.T., Habib F.K., Maitland N.J., and Neal D.E. Identification and isolation of human prostate epithelial stem cells based on alpha(2)beta(1)-integrin expression. J. Cell Sci. 114 (2001) 3865-3872
10. Richardson G.D., Robson C.N., Lang S.H., Neal D.E., Maitland N.J., and Collins A.T. CD133, a novel marker for human prostatic epithelial stem cells. J. Cell Sci. 117 (2004) 3539-3545
11. Nichols J., Zevnik B., Anastassiadis K., Niwa H., Klewe-Nebenius D., Chambers I., Scholer H., and Smith A. Formation of pluripotent stem cells in the mammalian embryo depends on the POU transcription factor Oct4. Cell 95 (1998) 379-391
12. Park I.K., Qian D., Kiel M., Becker M.W., Pihalja M., Weissman I.L., Morrison S.J., and Clarke M.F. Bmi-1 is required for maintenance of adult self-renewing haematopoietic stem cells. Nature 423 (2003) 302-305
13. Molofsky A.V., Pardal R., Iwashita T., Park I.K., Clarke M.F., and Morrison S.J. Bmi-1 dependence distinguishes neural stem cell self-renewal from progenitor proliferation. Nature 425 (2003) 962-967
14. Reya T., Morrison S.J., Clarke M.F., and Weissman I.L. Stem cells, cancer, and cancer stem cells. Nature 414 (2001) 105-111
15. Karhadkar S.S., Bova G.S., Abdallah N., Dhara S., Gardner D., Maitra A., Isaacs J.T., Berman D.M., and Beachy P.A. Hedgehog signalling in prostate regeneration, neoplasia and metastasis. Nature 431 (2004) 707-712
16. Litvinov I.V., Vander Griend D.J., Xu Y., Antony L., Dalrymple S.L., and Isaacs J.T. Low-calcium serum-free defined medium selects for growth of normal prostatic epithelial stem cells. Cancer Res. 66 (2006) 8598-8607
17. Miki J., Furusato B., Li H., Gu Y., Takahashi H., Egawa S., Sesterhenn I.A., McLeod D.G., Srivastava S., and Rhim J.S. Identification of putative stem cell markers, CD133 and CXCR4, in hTERT-immortalized primary nonmalignant and malignant tumor-derived human prostate epithelial cell lines and in prostate cancer specimens. Cancer Res. 67 (2007) 3153-3161
18. Gu G., Yuan J., Wills M., and Kasper S. Prostate cancer cells with stem cell characteristics reconstitute the original human tumor in vivo. Cancer Res. 67 (2007) 4807-4815
19. Harrington L. Does the reservoir for self-renewal stem from the ends?. Oncogene 23 (2004) 7283-7289
20. Soda H., Raymond E., Sharma S., Lawrence R., Davidson K., Oka M., Kohno S., Izbicka E., and Von Hoff D.D. Effects of androgens on telomerase activity in normal and malignant prostatecells in vitro. Prostate 43 (2000) 161-168
21. Sommerfeld H.J., Meeker A.K., Piatyszek M.A., Bova G.S., Shay J.W., and Coffey D.S. Telomerase activity: a prevalent marker of malignant human prostate tissue. Cancer Res. 56 (1996) 218-222
22. Ju Z., and Rudolph K.L. Telomeres and telomerase in cancer stem cells. Eur. J. Cancer 42 (2006) 1197-1203
23. Gu Y., Li H., Miki J., Kim K.H., Furusato B., Sesterhenn I.A., Chu W.S., McLeod D.G., Srivastava S., Ewing C.M., Isaacs W.B., and Rhim J.S. Phenotypic characterization of telomerase-immortalized primary non-malignant and malignant tumor-derived human prostate epithelial cell lines. Exp. Cell Res. 312 (2006) 831-843
24. Dalrymple S., Antony L., Xu Y., Uzgare A.R., Arnold J.T., Savaugeot J., Sokoll L.J., De Marzo A.M., and Isaacs J.T. Role of notch-1 and E-cadherin in the differential response to calcium in culturing normal versus malignant prostate cells. Cancer Res. 65 (2005) 9269-9279
25. Lang S.H., Stark M., Collins A., Paul A.B., Stower M.J., and Maitland N.J. Experimental prostate epithelial morphogenesis in response to stroma and three-dimensional matrigel culture. Cell Growth Differ. 12 (2001) 631-640
26. Li H., Velasco-Miguel S., Vass W.C., Parada L.F., and DeClue J.E. Epidermal growth factor receptor signaling pathways are associated with tumorigenesis in the Nf1:p53 mouse tumor model. Cancer Res. 62 (2002) 4507-4513
27. Li H., Ahonen T.J., Alanen K., Xie J., LeBaron M.J., Pretlow T.G., Ealley E.L., Zhang Y., Nurmi M., Singh B., Martikainen P.M., and Nevalainen M.T. Activation of signal transducer and activator of transcription 5 in human prostate cancer is associated with high histological grade. Cancer Res. 64 (2004) 4774-4782
28. Bieberich C.J., Fujita K., He W.W., and Jay G. Prostate-specific and androgen-dependent expression of a novel homeobox gene. J. Biol. Chem. 271 (1996) 31779-31782
29. Reiter R.E., Gu Z., Watabe T., Thomas G., Szigeti K., Davis E., Wahl M., Nisitani S., Yamashiro J., Le Beau M.M., Loda M., and Witte O.N. Prostate stem cell antigen: a cell surface marker overexpressed in prostate cancer. Proc. Natl. Acad. Sci. U. S. A. 95 (1998) 1735-1740
30. Signoretti S., Waltregny D., Dilks J., Isaac B., Lin D., Garraway L., Yang A., Montironi R., McKeon F., and Loda M. p63 is a prostate basal cell marker and is required for prostate development. Am. J. Pathol. 157 (2000) 1769-1775
31. Signoretti S., Pires M.M., Lindauer M., Horner J.W., Grisanzio C., Dhar S., Majumder P., McKeon F., Kantoff P.W., Sellers W.R., and Loda M. p63 regulates commitment to the prostate cell lineage. Proc. Natl. Acad. Sci. U. S. A. 102 (2005) 11355-11360
32. Signoretti S., and Loda M. Defining cell lineages in the prostate epithelium. Cell Cycle 5 (2006) 138-141
33. Battula V.L., Bareiss P.M., Treml S., Conrad S., Albert I., Hojak S., Abele H., Schewe B., Just L., Skutella T., and Buhring H.J. Human placenta and bone marrow derived MSC cultured in serum-free, b-FGF-containing medium express cell surface frizzled-9 and SSEA-4 and give rise to multilineage differentiation. Differentiation 75 (2007) 279-291
34. Guillot P.V., Gotherstrom C., Chan J., Kurata H., and Fisk N.M. Human first-trimester fetal MSC express pluripotency markers and grow faster and have longer telomeres than adult MSC. Stem Cells 25 (2007) 646-654
35. Baal N., Reisinger K., Jahr H., Bohle R.M., Liang O., Munstedt K., Rao C.V., Preissner K.T., and Zygmunt M.T. Expression of transcription factor Oct-4 and other embryonic genes in CD133 positive cells from human umbilical cord blood. Thromb. Haemost. 92 (2004) 767-775
36. Fernandes K.J., McKenzie I.A., Mill P., Smith K.M., Akhavan M., Barnabe-Heider F., Biernaskie J., Junek A., Kobayashi N.R., Toma J.G., Kaplan D.R., Labosky P.A., Rafuse V., Hui C.C., and Miller F.D. A dermal niche for multipotent adult skin-derived precursor cells. Nat. Cell Biol. 6 (2004) 1082-1093
37. Chunmeng S., and Tianmin C. Skin: a promising reservoir for adult stem cell populations. Med. Hypotheses 62 (2004) 683-688
38. Trosko J.E. From adult stem cells to cancer stem cells: Oct-4 Gene, cell-cell communication, and hormones during tumor promotion. Ann. N.Y. Acad. Sci. 1089 (2006) 36-58
39. Ponti D., Costa A., Zaffaroni N., Pratesi G., Petrangolini G., Coradini D., Pilotti S., Pierotti M.A., and Daidone M.G. Isolation and in vitro propagation of tumorigenic breast cancer cells with stem/progenitor cell properties. Cancer Res. 65 (2005) 5506-5511
40. Sagrinati C., Netti G.S., Mazzinghi B., Lazzeri E., Liotta F., Frosali F., Ronconi E., Meini C., Gacci M., Squecco R., Carini M., Gesualdo L., Francini F., Maggi E., Annunziato F., Lasagni L., Serio M., Romagnani S., and Romagnani P. Isolation and characterization of multipotent progenitor cells from the Bowman's capsule of adult human kidneys. J. Am. Soc. Nephrol. 17 (2006) 2443-2456
41. Kucia M., Halasa M., Wysoczynski M., Baskiewicz-Masiuk M., Moldenhawer S., Zuba-Surma E., Czajka R., Wojakowski W., Machalinski B., and Ratajczak M.Z. Morphological and molecular characterization of novel population of CXCR4+SSEA-4+Oct-4+ very small embryonic-like cells purified from human cord blood: preliminary report. Leukemia 21 (2007) 297-303
42. Roche S., Richard M.J., and Favrot M.C. Oct-4, Rex-1, and Gata-4 expression in human MSC increase the differentiation efficiency but not hTERT expression. J. Cell. Biochem. 101 (2007) 271-280
43. Yen M.L., Chien C.C., Chiu I.M., Huang H.I., Chen Y.C., Hu H.I., and Yen B.L. Multilineage differentiation and characterization of the human fetal osteoblastic 1.19 cell line: a possible in vitro model of human mesenchymal progenitors. Stem Cells 25 (2007) 125-131
44. Ratajczak M.Z., Machalinski B., Wojakowski W., Ratajczak J., and Kucia M. A hypothesis for an embryonic origin of pluripotent Oct-4(+) stem cells in adult bone marrow and other tissues. Leukemia 21 (2007) 860
45. Peehl D.M. Are primary cultures realistic models of prostate cancer?. J. Cell. Biochem. 91 (2004) 185-195
46. Bodnar A.G., Ouellette M., Frolkis M., Holt S.E., Chiu C.P., Morin G.B., Harley C.B., Shay J.W., Lichtsteiner S., and Wright W.E. Extension of life-span by introduction of telomerase into normal human cells. Science 279 (1998) 349-352
47. Wang Y., Revelo M.P., Sudilovsky D., Cao M., Chen W.G., Goetz L., Xue H., Sadar M., Shappell S.B., Cunha G.R., and Hayward S.W. Development and characterization of efficient xenograft models for benign and malignant human prostate tissue. Prostate 64 (2005) 149-159
48. Huss W.J., Gray D.R., Werdin E.S., Funkhouser Jr. W.K., and Smith G.J. Evidence of pluripotent human prostate stem cells in a human prostate primary xenograft model. Prostate 60 (2004) 77-90
49. Donjacour A.A., and Cunha G.R. Assessment of prostatic protein secretion in tissue recombinants made of urogenital sinus mesenchyme and urothelium from normal or androgen-insensitive mice. Endocrinology 132 (1993) 2342-2350
50. Cunha G.R., and Lung B. The possible influence of temporal factors in androgenic responsiveness of urogenital tissue recombinants from wild-type and androgen-insensitive (Tfm) mice. J. Exp. Zool. 205 (1978) 181-193
51. Lawson D.A., Xin L., Lukacs R.U., Cheng D., and Witte O.N. Isolation and functional characterization of murine prostate stem cells. Proc. Natl. Acad. Sci. U. S. A. 104 (2007) 181-186
52. Xin L., Lawson D.A., and Witte O.N. The Sca-1 cell surface marker enriches for a prostate-regenerating cell subpopulation that can initiate prostate tumorigenesis. Proc. Natl. Acad. Sci. U. S. A. 102 (2005) 6942-6947